Antibody therapy in pancreatic cancer: mAb-ye we're onto something? (2021)
Attributed to:
The development of bispecific antibodies to promote proapoptotic immunotherapy in pancreatic cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bbcan.2021.188557
PubMed Identifier: 33945846
Publication URI: http://europepmc.org/abstract/MED/33945846
Type: Journal Article/Review
Volume: 1876
Parent Publication: Biochimica et biophysica acta. Reviews on cancer
Issue: 1
ISSN: 0304-419X